Insider · CIK 0001926254
Jeffrey S. Hackman
Files at FENC (FENNEC PHARMACEUTICALS INC.). First filing May 19, 2025, latest May 19, 2025.
In brief
Jeffrey S. Hackman files SEC Form 4 as CEO and director at FENC (FENNEC PHARMACEUTICALS INC.). Since May 19, 2025, Jeffrey S. Hackman has reported 1 open-market buy worth $105k and 0 open-market sells worth $0, the latest filed on May 19, 2025.
A track record needs three past buys with six months of prices behind them; Jeffrey S. Hackman has 0, so none is measured yet.
The newest scored trade: bought $105k of FENC on May 16, 2025, filed May 19, 2025, scored 43 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
FENC: FENNEC PHARMACEUTICALS INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | FENCbuy FENNEC PHARMACEUTICALS INC. | $105k 15,000 shares | - | +71% from low-3% from high |
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 12, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common Shares | +2,224 | $5.53 | $12k | 69,685 | 4 h ago |
| Sep 30, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common Shares | +1,159 | $0.00 | $0 | 67,461 | 13 d ago |
| Aug 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common Shares | +1,159 | $0.00 | $0 | 66,302 | 44 d ago |
| Jul 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common Shares | +1,159 | $0.00 | $0 | 65,143 | Aug 3, 2026 |
| Jun 30, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common Shares | +1,159 | $0.00 | $0 | 63,984 | Jul 1, 2026 |
| May 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common Shares | +1,159 | $0.00 | $0 | 62,825 | Jun 1, 2026 |
| Apr 30, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common Shares | +1,159 | $0.00 | $0 | 61,666 | May 1, 2026 |
| Mar 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common Shares | +16,695 | $0.00 | $0 | 45,405 | Apr 2, 2026 |
| Mar 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common Shares | +1,159 | $0.00 | $0 | 46,564 | Apr 2, 2026 |
| Mar 28, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common Shares | +13,943 | $0.00 | $0 | 60,507 | Apr 2, 2026 |
| Mar 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Stock Optionsderivative | +200,000 | $5.77 | $1.2M | 725,000 | Apr 2, 2026 |
| Feb 18, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common Shares | +13,710 | $0.00 | $0 | 28,710 | Feb 19, 2026 |
| May 16, 2025 | FENC FENNEC PHARMACEUTICALS INC. | POpen-market purchase Common Shares | +1,035 | $6.75 | $6,986 | 1,035 | May 19, 2025 |
| May 19, 2025 | FENC FENNEC PHARMACEUTICALS INC. | POpen-market purchase Common Shares | +13,965 | $6.99 | $98k | 15,000 | May 19, 2025 |
| Mar 28, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Restricted Share Unitderivative | +75,000 | $0.00 | $0 | 75,000 | Apr 3, 2025 |
| Mar 28, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Restricted Share Unitderivative | +75,000 | $0.00 | $0 | 475,000 | Apr 3, 2025 |
| Mar 28, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Stock Optionsderivative | +50,000 | $0.00 | $0 | 450,000 | Apr 3, 2025 |
| Mar 28, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Stock Optionsderivative | +50,000 | $0.00 | $0 | 525,000 | Apr 3, 2025 |
Questions about Jeffrey S. Hackman
Answered from the filings on this page, as of the latest one.
Is Jeffrey S. Hackman buying or selling?
Not in the last 12 months. Jeffrey S. Hackman's latest open-market trade on SEC Form 4 was bought $105k of FENC on May 16, 2025.
How did Jeffrey S. Hackman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jeffrey S. Hackman has 0.
Where does Jeffrey S. Hackman file Form 4?
Jeffrey S. Hackman has filed Form 4 at FENC (FENNEC PHARMACEUTICALS INC.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.